Smartphone intervention improves medication adherence in diabetes patients
This study evaluated the impact of a smartphone-based intervention on medication adherence in adults with Type 2 diabetes and hypertension in Ghana, finding mixed results.
Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the impact of a smartphone-based intervention on medication adherence in adults with Type 2 diabetes and hypertension in Ghana, finding mixed results.
This Phase II study evaluated the effects of Survodutide on HbA1c levels and bodyweight in adults with Type 2 Diabetes, finding significant reductions in both outcomes compared to baseline.
Tirzepatide treatment significantly improved cardiometabolic risk factors in adults with obesity or overweight.
The study analyzed the efficacy of tirzepatide in patients with type 2 diabetes, showing significant reductions in HbA1c, body weight, and fasting serum glucose.
This study analyzed the sustainability of glycemic control and weight loss with tirzepatide in type 2 diabetes patients, showing significant maintenance of HbA1c and weight loss.
This study evaluated the efficacy and durability of initial combination therapies for Type 2 Diabetes, finding that initial triple therapy showed lower liver fat content compared to sequential therapy.
This study evaluated the impact of the Vitadio digital health application on glycemic control in patients with Type 2 Diabetes Mellitus, finding significant improvements in several health metrics.
This study investigated the effects of vitamin D3 supplementation on inflammation in type 2 diabetes patients, finding significant reductions in various inflammatory markers.
A study found that supervised home-based elastic band exercises significantly improved health outcomes in pre-frail older adults with type 2 diabetes.
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.